Since its establishment in 2012, the Henry Chanoch Krenter Institute for Biomedical Imaging and Genomics has become a driving force behind advanced cancer and biomedical imaging research at the Weizmann Institute of Science and a catalyst for original research projects in these fields.
The Institute supports laboratory research, equipment acquisition, and scientific exchanges. Promoting collaborative projects between experts in both bioimaging and genomics, the Institute helps Weizmann scientists reach their goal: to elucidate the complex mechanisms of cancer.